Showing results (71-80 of 1,984) with videos related to
Sort By:
Pageof 199
Statistics in Medicine|October 12, 2021
Precision Bayesian phase I-II dose-finding based on utilities tailored to prognostic subgroupsJuhee Lee, Peter F Thall, Pavlos MsaouelStatistics in Biosciences|July 30, 2010
Evaluating the Impact of Prior Assumptions in Bayesian BiostatisticsSatoshi Morita, Peter F Thall, Peter MüllerBiometrics|September 4, 2007
Determining the effective sample size of a parametric priorSatoshi Morita, Peter F Thall, Peter MüllerBiometrics|October 17, 2014
Bayesian nonparametric estimation of targeted agent effects on biomarker change to predict clinical outcomeRebecca Graziani, Michele Guindani, Peter F ThallCancers|October 14, 2023
Interpreting Randomized Controlled TrialsPavlos Msaouel, Juhee Lee, Peter F ThallPharmaceutical Statistics|January 24, 2017
A simulation study of methods for selecting subgroup-specific doses in phase 1 trialsSatoshi Morita, Peter F Thall, Kentaro TakedaBiometrics|August 17, 2022
Bayesian treatment screening and selection using subgroup-specific utilities of response and toxicityJuhee Lee, Peter F Thall, Pavlos MsaouelJournal of Surgical Oncology|July 15, 2024
Signet ring cells and conditional survival after trimodality therapy for esophageal adenocarcinomaKyle G Mitchell, Hope Feldman, Denái R Milton, et al.Statistics in Medicine|January 31, 2022
TITE-BOIN12: A Bayesian phase I/II trial design to find the optimal biological dose with late-onset toxicity and efficacyYanhong Zhou, Ruitao Lin, J Jack Lee, et al.Biometrics|July 14, 2005
Determining a maximum-tolerated schedule of a cytotoxic agentThomas M Braun, Zheng Yuan, Peter F ThallPageof 199